Olympus Biomaterial Corp. To Take Over Sumitomo Pharmaceuticals Co. Ltd.'s Bone Replacement Material Business
10/19/2005 5:10:20 PM
Tokyo (JCNN) - On May 11, Olympus Biomaterial, Sumitomo Osaka Cement (TSE: 5232) and Sumitomo Pharmaceuticals jointly announced that they have reached a basic agreement on a forthcoming transfer of bone replacement material business currently co-conducted by Sumitomo Osaka Cement and Sumitomo Pharmaceuticals. Olympus Biomaterial is scheduled to take over Sumitomo's bone replacement material business by the end of June.
comments powered by